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Salmonellae are bacterial pathogens that have
evolved sophisticated strategies to evade host im-
mune defenses. These strategies include the secre-
tion of effector proteins into mammalian cells so as
to subvert innate immune and apoptotic signaling
pathways, thereby allowing Salmonella to avoid
elimination. Here, we show that the secreted Salmo-
nella typhimurium effector protein AvrA possesses
acetyltransferase activity toward specific mitogen-
activated protein kinase kinases (MAPKKs) and
potently inhibits c-Jun N-terminal kinase (JNK) and
NF-kB signaling pathways in both transgenic Dro-
sophila and murine models. Furthermore, we show
that AvrA dampens the proapoptotic innate immune
response to Salmonella at the mouse intestinal
mucosa. This activity is consistent with the natural
history of Salmonella in mammalian hosts, where
the bacteria elicit transient inflammation but do not
destroy epithelial cells. Our findings suggest that
targeting JNK signaling to dampen apoptosis may
be a conserved strategy for intracellular pathogens.
INTRODUCTION
All multicellular organisms possess the ability to respond to and
managemicrobial threats. This process involves transmembrane
pattern recognition receptors that perceive the macromolecular
signatures of microbes and set in motion cytoplasmic signaling
cascades, which subsequently activate nuclear transcription
factors and ultimately induce the transcriptional synthesis of
antimicrobial, proinflammatory, and cytoprotective genes that
serve to eradicate microbes and limit/repair damage. Alterna-
tively, and often in parallel, microbial stresses induce apoptotic
signaling, which in certain short lived cell types—such as intesti-
nal epithelia—also serve to eradicate invasive pathogens. This
framework of recognition, response, and repair, or focal apopto-
tic cell loss, has examples in plants, invertebrates, andmammals.
Key signaling pathways involved in these defenses against
microbes include the mitogen-activated protein kinase (MAPK)
pathways. The MAPKs function in a triple kinase sequence thatinvolves the rapid and controlled relay of phosphorylation events
to convey ‘‘alarm’’ signals (Roux and Blenis, 2004). Perception of
diverse threats induces the upstream activators, kinases of the
MAPKKK class. These proteins serve to activate the MAPKKs
(orMEKKs),which subsequently activate theMAPKsandadown-
stream battery of immune and cell survival effector systems.
MAPKKs such as MKK6 and MKK3 phosphorylate and activate
members of the ERK and p38 MAPKs, respectively, which medi-
ate primarily proliferative and cytoprotective responses. In con-
trast, the MAPKK MKK4/7 activates Jun N-terminal kinase
(JNK), which is proinflammatory or, during prolonged activation,
potently proapoptotic (Weston and Davis, 2007). In parallel,
kinases of the IkB kinase family (IKKs)—which are closely struc-
turally related to the MAPKKs—set in motion the NF-kB/Rel
pathway by phosphorylation of IkB. This leads to proteasomal-
mediated degradation of IkB and subsequent activation of
NF-kB by nuclear translocation and induction of innate immune
andantiapoptotic geneproducts. The involvement ofMAPK family
members in cellular responses to microbes are highly conserved
across eukaryotic life, including animals and plants. Recognizable
orthologs of themammalianMAPKs, IKKs, andRel factors arewell
described in vertebrates and arthropods (Hoffmann, 2003;
Lemaitre and Hoffmann, 2007; Silverman and Maniatis, 2001).
Given the central role MAPKs and Rel pathways play in antimi-
crobial signaling, it is not surprising that some bacterial patho-
gens have evolved mechanisms to surmount their effects.
Bacterial inhibition of NF-kB has been described at the level of
IkB phosphorylation (Ruckdeschel et al., 1998), nuclear translo-
cation (Kelly et al., 2004), and in past data from our laboratory at
the level of IkB ubiquitination (Neish et al., 2000). Inhibition of
MAPKs has been described in Yersinia, Shigella, and anthrax
infections (Duesbery et al., 1998; Li et al., 2007; Orth et al.,
1999). It is generally assumed that bacterial pathogens evolved
these capacities to prevent or reduce the upregulation of the
inflammatory response, thus blocking the influx of phagocytic
leukocytes, and/or to activate or augment apoptotic pathways
in immunoregulatory cells such as macrophages—both events
likely permissive for bacterial proliferation and dissemination.
Bacteria can influence host cell signaling pathways via soluble
effector proteins that are often translocated into the host cells or
the environment via a ‘‘type III secretion apparatus’’ (Staskawicz
et al., 2001). The effector proteins are generally assumed to
usurp host cellular functions for the benefit of the invading
organism and consequently are often designated as toxins orCell Host & Microbe 3, 233–244, April 2008 ª2008 Elsevier Inc. 233
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inhibitory effects on MAPKs is the YopJ/AvrA family. These pro-
teins have been detected in a variety of bacteria that associate
intimately with eukaryotic hosts. YopJ of Yersinia enterocolitica
was shown to inhibit both multiple MAPK and NF-kB pathways,
inducing rapid apoptotic death in infected macrophages (Orth
et al., 1999; Ruckdeschel et al., 1998). Orthologs of this protein
are found in other enteric pathogens such as Vibrio parahemaly-
ticus, VopA (Trosky et al., 2004) and Aeromonas salmonicida,
AopP (Fehr et al., 2006), and in a spectrum of plant pathogens
(Ellis et al., 2007). Intriguingly, an ortholog is present in Rhizobia
sp, a nitrogen-fixing plant symbiont (Freiberg et al., 1997), sug-
gesting that members of this class of proteins are found in
a wide variety of bacteria that mediate both pathogenic and
symbiotic relationships, presumably by manipulating host innate
immune signaling pathways.
Another member of this family is AvrA, a Salmonella typhimu-
rium protein that is translocated into intestinal epithelial cells
during the initial stages of invasion (Hardt and Galan, 1997).
We have shown that AvrA overexpressed in transfected cells
blocked NF-kB translocation and transcriptional activation of
inflammatory effector genes (Collier-Hyams et al., 2002). To fur-
ther understand its effects on cellular signaling pathways in vivo,
we have exploited directed expression of AvrA in Drosophila
melanogaster. Unlike experiments previously carried out with
cultured mammalian cells, Drosophila allows investigation of
the physiological effects of AvrA in an intact animal through
well-defined genetic approaches using tissue-specific and
inducible expression systems. We show that AvrA is a potent
inhibitor of the Drosophila IMD pathway in response to Gram-
negative infection, but only marginally affects the Toll pathway,
which is activated in response to Gram-positive or fungal infec-
tion. Remarkably, immune blockade occurs without induction of
apoptotic cell death characteristically seen during inhibition of
host stress signaling pathways. We show that AvrA expression
resulted in a potent blockade of JNK activation at the level of
the MAPKKMEKK4/7 in both flies and human cells and inhibited
JNK-mediated apoptosis. Consistent with this finding, we show
that AvrA Salmonella induced higher levels of inflammation,
JNK activation, and epithelial apoptosis in infected murine intes-
tine. Previously, experiments using extended colonization of cul-
tured HeLa cells by nonproinflammatory Salmonella strains sug-
gested that AvrA played a proapoptotic role (Collier-Hyams
et al., 2002). However, here, using a pathogenic Salmonella
strain and two whole-organism models, we provide data sug-
gesting that the AvrA effector can inhibit innate immune re-
sponses in a eukaryotic host without the induction of apoptosis.
Thus, an intracellular pathogen can ‘‘quiet’’ both inflammatory
and apoptotic defenses.
RESULTS
AvrA Expression in the Drosophila Fat Body Suppresses
Imd Pathway Activation
To investigate AvrA function in the context of a whole animal, we
generated transgenic Drosophila harboring either wild-type
Salmonella typhimurium protein AvrA or a catalytically inactive
mutant form of AvrA (mAvrA) (C186A transition) under the tran-
scriptional control of the UAS promoter, allowing tissue specific
234 Cell Host & Microbe 3, 233–244, April 2008 ª2008 Elsevier Inc.expression by crossing to GAL4 driver lines (Brand, 1994).
Appropriate expression was determined by immunoblot analysis
of fly tissue (Figure S1A available online). No toxicity was
observed with AvrA expression in larval or adult animals. We
examined whether expression of AvrA in the Drosophila fat
body (the site of fly systemic immune response) could suppress
innate immunity. Flies expressing AvrA had a greater mortality
rate compared to flies expressing mAvrA following parenteral
Gram-negative infections with Escherichia coli or Erwinia caroto-
vora (Figure 1A), while control and mAvrA-expressing flies had
similar mortality rates. Flies expressing AvrA infected with either
the Gram-positive bacteria Micrococcus luteus or Bauvaria
basiana fungal spores did not result in a detectable reduction
in survival rates (Figure 1A), suggesting specificity of immuno-
suppression toward Gram-negative bacteria.
Fat body expression of AvrA inhibited the Erwinia carotovora
stimulated upregulation of transcripts encoding the anti-Gram
negative specific peptide Diptericin (Figure 1B), and also
inhibited a Diptericin promoter driven reporter construct (Fig-
ure 1C) relative to the increased expression of Diptericin mea-
sured in control or mAvrA expressing flies. AvrA expression
had a minimal inhibitory effect on theMicrococcus luteus stimu-
lated upregulation of the anti-Gram positive-peptide Drosomycin
(Figure 1B) or a Drosomycin reporter construct (Figure 1C).
To directly implicate AvrA activity on Drosophila immune
signaling, we evaluated the activation of the Toll pathway tran-
scription factor Dif and the imd transcription factor Relish in
response to immune challenge. Upon activation, Dif and Relish
are translocated to the nucleus where they initiate the upregula-
tion of antimicrobial peptides production (diagrammed in
Figure S2) (Lemaitre and Hoffmann, 2007). Larvae expressing
either AvrA ormAvrA in their fat bodieswere parenterally infected
with either Gram-negative or Gram-positive bacteria. Relish
translocation was completely inhibited in AvrA-expressing tissue
following Gram-negative infection (Figure 1D), while AvrA had no
inhibitory effect on Dif translocation (Figure 1E). Collectively,
these data show that AvrA expression in the fat body of adult
Drosophila selectively interferes with responses to Gram-nega-
tive infection (IMD pathway).
AvrA Expression Is Not Proapoptotic and Inhibits
JNK/Bsk Phosphorylation and Caspase-3/Drice
Activation in Response to Constitutive dTAK
or Eiger Expression
The IMD/Relish pathway is tightly intertwined with apoptotic
signaling intermediates such as the c-Jun N-terminal Kinase
(JNK) (Liu and Lin, 2007). Furthermore, inhibition of Rel pathways
is known to potently stimulate proapoptotic pathways in many
systems and cell types.Drosophila offers an exquisitely sensitive
system for assay of direct proapoptotic potential of expressed
proteins by ectopic expression to the developing retina. We
thus used the GMR-Gal4 driver to express AvrA immediately
posterior to the morphogenetic furrow, allowing a spatial and
temporal evaluation of apoptotic effects on the epithelial cells
of the developing retina (Figure S3A). Surprisingly, AvrA (and
the mutant form) had no discernable effects on gross appear-
ance of the adult eye or any evidence of cell death (Figure 2A).
This is in contrast to the ‘‘rough eye’’ phenotype induced as a
result of the expression of two paralogs of AvrA: AopP from
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exhibit inhibitory effects on NF-kB signaling but having no effect
on MAPK signaling (Fehr et al., 2006), and the Vibrio protein
VopA (Figure S3C; Figure 2B), reported to block ERK and JNK
MAPK signaling while having no effect on NF-kB signaling
(Trosky et al., 2007; Trosky et al., 2004). Importantly, the rough
eye phenotype exhibited by AopP could be reversed by overex-
pression of Drosophila inhibitor of apoptosis (dIAP) and the
IAP-like molecule p35, confirming this protein is directly proa-
poptotic (Figure 2A). Additionally, the VopA-mediated rough
eye was reversed upon coexpression of activated Rolled (Dro-
sophila ERK), confirming the ERK inhibitory role of VopA and
showing that AvrA does not have inhibitory affects on the ERK
MAPK pathway (Figure 2B). We also found that AvrA had no
Figure 1. AvrA Expression in the Drosophila Fat Body Suppresses Innate Immunity in Response to Gram-Negative, but Not Gram-Positive,
Infection
(A) Survival rates of the flies expressing AvrA (c564-GAL4 UAS-avrA or of the isogenic fly harboring UAS-mavrA), following parenteral Gram-negative E. caroto-
vora or E. coli infection, and Gram-positive infection Micrococcus luteus or natural Bauvaria bassiana fungal infection. Relish mutant flies (relE20) susceptible to
Gram-negative and spatzle (spz) null flies susceptible to fungal infections were used as controls. Results represent the average of triplicate studies and error bars
represent standard deviation.
(B) Quantitative RT-PCR analysis of diptericin and drosomycin gene expression in flies infected with E. carotovora or M. luteus. PCR reactions were done in
triplicate using two separate RNA preparations for each data point. Error bars represent SEM.
(C) b-galactosidase assays and GFP measurements of E. carotovora- and M. luteus-infected flies harboring DD1 (y, w, P(ry+, Dpt-lacZ), P(w+, Drs-GFP)), yolk-
GAL4;UAS-avrA, or of the isogenic fly harboring UAS-mavrA. Values for b-galactosidase activity and GFP determinations were normalized with respect to protein
concentration. Assays were done in triplicate using two separate extract preparations for each data point. Error bars represent SEM.
(D) Fat body tissue from E. caratavora infected larvae was analyzed for Relish distribution by immunostaining using an antibody against the N-terminal domain of
Relish.
(E) Fat body tissue from M. luteus infected third-instar larvae expressing AvrA or mAvrA was fixed and analyzed for Dif protein distribution by immunostaining
using an anti-Dif antibody.
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Salmonella AvrA Suppresses JNK-Mediated ApoptosisFigure 2. AvrA Expression Is Not Proapoptotic and Inhibits JNK/Bsk Phosphorylation and Caspase-3/Drice Activation in Response to Con-
stitutive dTAK or Eiger Expression
(A) Phenotypes of Adult Drosophila Expressing AvrA, mAvrA, AopP, or mAopP under the eye-specific driver GMR-GAL4. Suppression of AopP-mediated small
eye phenotypes by p35 or dIAP confirm the phenotype is a result of apoptotic events.
(B) Phenotypes of adult Drosophila expressing VopA or mVopA under the eye-specific driver GMR-GAL4. Suppression of VopA-mediated small eye phenotypes
by overexpression of activated Rolled (Drosophila ERK) confirms the VopA rough eye phenotype is due to ERK pathway inhibition.
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ture, even when cells were treated with TNF-a, whereas,
consistent with previous reports, cells transfected with YopJ
exhibited an increased number of cells with an apoptotic pheno-
type (Figure S4A), TUNEL (Figures S4B and S4C), and annexin V
positivity (Figure S4D). Thus, we conclude that AvrA does not
possess any direct proapoptotic activity, which is in striking
contrast to paralogs encoded by other pathogens.
In flies andmammals, a key regulator of both inflammatory and
apoptotic signaling is the MAPKKK TAK-1 (diagrammed in
Figure S2) (Sato et al., 2005; Vidal et al., 2001). In flies, TAK-1
is a central regulator of the IMD immune pathway, and constitu-
tive expression of TAK-1 signaling is proapoptotic (Takatsu et al.,
2000). Immune-mediated (and TAK-1-dependent) apoptosis in
flies and mammals can be mediated by prolonged and unop-
posed JNK signaling, events that can be physiologically antago-
nized by phosphatases induced via simultaneous and parallel
Rel pathway activation, to allow immune responses in the
absence of apoptosis (Kamata et al., 2005; Park et al., 2004).
Third-instar retinal imaginal disk constitutive expression of
dTAK-1 resulted in a strong small eye phenotype consistent
with past reports (Leulier et al., 2002) (Figure 2C). Strikingly,
AvrA coexpressed with dTAK-1 nearly completely suppressed
the small eye phenotype, while mAvrA had no effect
(Figure 2C). Drosophila Eiger/Wengen, the ortholog of mamma-
lian TNF/TNF-R, is a potent and specific activator of JNK signal-
ing and apoptosis (Moreno et al., 2002). Constitutive expression
of Eiger in the retina resulted in an extreme small eye phenotype,
consistent with past reports (Igaki et al., 2002) (Figure 2E).
Constitutive expression of Eiger, an extra cellular cytokine, has
the advantage of activating signaling without potential artifacts
caused by intracellular constitutive expression of a cytoplasmic
kinase. Again, AvrA expression was able to totally suppress this
phenotype, while the mutant form did not. TAK-1 is a MAPKKK
that functions as a JNK-KK. Hemipterous (MKK4/7 in mammals)
is the subsequent MAPKK (JNK-K) in the JNK pathway (dia-
grammed in Figure S2). Constitutive expression of Hemipterous
(UAS-hep) or Basket (UAS-bsk) in the Drosophila eye did not
activate the JNK pathway and did not result in a small eye
phenotype. However, concurrent constitutive expression of
UAS-hep and UAS-bsk under GMR-GAL4 strongly activates
the JNK pathway and is lethal in Drosophila at the pupal stage
of development. AvrA expression in the GMR-GAL4 UAS-hep
UAS-bsk genetic background resulted in a viable adultDrosoph-
ila exhibiting a mild rough eye phenotype (Figure 2G), whereas
expression of mAvrA could not rescue the lethal phenotype. Fi-
nally, a constitutively active allele of Hemipterous (UAS-hep(act))
(Amino acid replacement: S326D and T330D in the kinase activa-
tion loop) also mediated a rough eye phenotype when driven byGMR-GAL4. Importantly, this phenotype could not be reversed
by AvrA expression (Figure 2G). Together, these epistatic data
indicate that AvrA inhibits the JNK pathway at the level of Hemip-
terous (MKK4/7) in Drosophila.
To confirm that apoptotic inhibitory effects were due to JNK
pathway blockade, we subjected third-instar eye imaginal disks
to immunostaining with anti-phospho-JNK antibodies. As
expected, both eye disk-specific TAK-1 and Eiger-constitutive
expression resulted in a strong activation of phospho-JNK
immediately distal to themorphogenetic furrow that was concur-
rent with appearance of active capase-3 (Figures 2C–2F). Both
phospho-JNK and active caspase-3 activity were suppressed
by AvrA expression, but not mutant AvrA. Finally, levels of phos-
phorylated JNK in flies expressing AvrA in the fat body following
Gram-negative infection were analyzed by immunoblot of fat
body lysates. There was only a trace increase in phosphorylated
JNK 30 min postinfection in flies expressing AvrA in the fat body
compared to wild-type flies or those expressing mAvrA
(Figure 2H), indicating AvrA could suppress microbially stimu-
lated JNK signaling.
AvrA Expression Represses the JNK Pathway
in Mammalian Cell Culture
To determine if our findings showing inhibition of JNK signaling
extended to a mammalian system, we expressed AvrA and
mAvrA in human 293T cells. Transfection efficiency was esti-
mated at >80% by transfecting a plasmid harboring GFP coding
sequence. Cells transfected with plasmids harboring AvrA or
mAvrA as well as YopJ (which served as positive control) were
stimulated with TNF-a, and cell lysates were analyzed by immu-
noblot for various endogenous signaling intermediates. While
JNK was phosphorylated within 15 min of TNF-a addition in
mAvrA and vector-only control, a complete blockade of JNK
phosphorylation occurred in cells transfected with AvrA
(Figure 3A). Note that unphosphorylated JNK increased in cells
transfected with AvrA, but not mutant AvrA. In contrast, AvrA
had no effect on TNF-a-induced phosphorylation of ERK or
p38. Inhibition of TNF-a-induced phosphorylation of ERK, JNK,
and, to a lesser extent, p38 occurred in cells transfected with
YopJ (Figure 3A), whereas cells transfected with mYopJ had
similar profiles to mAvrA-transfected cells (data not shown).
Additionally, AvrA had no affect on TAK-1 phosphorylation in
response to TNF-a stimulation (Figure 3B), indicating that AvrA
inhibits the JNK pathway in mammalian cells distal to TAK-1.
Also, AvrA expression resulted in partial stabilization of IkB-
a (Figure 3C) while having little or no effect on TNF-a induced
IkB-a phosphorylation consistent with past experiments (Col-
lier-Hyams et al., 2002). Finally, AvrA, but not mAvrA expression,
could repress JNK-dependent reporter gene expression while(C) Phenotypes of adult Drosophila eyes resulting from dTAK overexpression and from a combination of dTAK1 and AvrA overexpression, with genotypes
indicated. Third-instar larval eye disks were immunostained for p-JNK and active caspase-3.
(D) Immunoblot analysis for p-JNK levels in larval eye imaginal disks from genotypes examined in (C).
(E) Phenotypes of adult eyes resulting from the Eiger overexpression and from a combination of Eiger and AvrA overexpression with genotypes indicated.
Third-instar larval eye disks were immunostained as above.
(F) Immunoblot analysis for p-JNK levels in larval eye imaginal disks from genotypes examined in (E).
(G) Phenotypes of adult Drosophila eyes resulting from activated hep overexpression and from a combination of activated hep and AvrA overexpression in the
Drosophila eye.
(H) Parenteral E. caratavora infection of third-instar larvae expressing AvrA in the fat body. Larval fat body was dissected at time points up to 1 hr postinfection and
analyzed for p-JNK by immunoblot.
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comparison, YopJ exhibited the expected inhibition of the JNK,
p38, and ERK pathways (Figure 3D). Thus, AvrA is a potent
inhibitor of the JNK pathway with partial effects on the NF-kB
pathway.
AvrA Inhibits JNK Pathway Activation
at the Level of MKK4/7 by Acetylation
In Drosophila, AvrA rescued dTAK1-mediated rough eye pheno-
type, but not the small eye phenotype caused by overexpression
of an activated form of Hemipterous (DrosophilaMKK4/7). Addi-
tionally, AvrA did not inhibit TAK1 phosphorylation. This sug-
gests AvrA inhibits the JNK pathway at the level of the MAPKK.
Thus, we probed TNFa-stimulated cell lysates with an antibody
against phospho-MKK4 and found that activation of this JNK
kinase was significantly reduced (Figure 3A). Furthermore, we
activated the JNK pathway in human-cultured cells with plas-
mids harboring JNK1 and MKK4 or MKK7. Previous reports
have shown cotransfection of JNK1 and MKK7 induced JNK
phosphorylation (Lei et al., 2002). AvrA cotransfection, but not
mAvrA, could totally abolish both MKK4- or MKK7-mediated
JNK phosphorylation (Figures 4A and 4B), thus indicating that
AvrA mediates JNK pathway inhibition at the level of MKK4
and MKK7.
Previous reports have shown that the AvrA homolog YopJ
mediates inhibition of the MAPK pathway by acting as an acetyl-
transferase, using acetyl-coenzyme A (CoA) to modify both Ser
and Thr residues in the activation loop of MKK6 and IKKb,
thereby blocking phosphorylation (Mittal et al., 2006; Mukherjee
et al., 2006). In order to determine whether AvrA has similar ace-
tyltransferase activity onMKK4, we analyzed tryptic digests from
lysates obtained by the co-transfection of pCMV-mycMKK4with
pcDNA-flagAvrA by mass spectrometry. Data revealed an
increase of 42 amu at K260 and Thr261 active site residue of the
MKK4 consistent with an O-acetylation of an amino acid residue
(Figure 4C and Figure 4D). We found no evidence of acetylation
at the Ser257 active site residue in tryptic digests including this
residue. Control experiments where MKK4 was transfected
Figure 3. AvrA Expression Represses the JNK Pathway in Mammalian Cell Culture
(A) 293T cultures cells transfected with vector control or plasmids harboring AvrA, mAvrA, or YopJ were stimulated with 10 ng/ml TNF-a over 1 hr and assayed by
immunoblot with the indicated antibodies.
(B) 293T cultured cells transfected with vector control or plasmids harboring AvrA or mAvrA were stimulated with 10 ng/ml TNF-a over 10 min in the presence of
10 ng/ml Calyculin A and assayed by immunoblot using anti-phospho TAK1 antibody.
(C) 293T cultured cells transfected with vector control or plasmids harboring AvrA or mAvrA were stimulated with 10 ng/ml TNF-a over 1 hr and assayed for IkB or
phospho IkB.
(D) JNK, p38, or ERK signaling pathways activation levels in 293T cells were measured by PathDetect (Stratagene) luciferase reporter gene assay in the presence
of plasmids harboring AvrA, mAvrA, YopJ, or mYopJ, respectively. Luciferase reporter gene assays were done in triplicate using two separate extract prepara-
tions for each data point. Experimental results are recorded as percent expression relative to measurements in cells expressing vector alone. Error bars indicate
SEM.
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(A) Immunoblot analysis for phospho-JNK activity in lystaes of HeLa cultured cells transfected with the indicated plasmids. Myc antibody detects JNK at 45 kDa
and AvrA/mAvrA at 34 kDa.
(B) Immunoblot analysis for phospho-JNK activity in lystaes of HeLa cultured cells transfected with the indicated plasmids. Myc antibody detects JNK at 45 kDa
and MKK4 42 kDa. Flag antibody detects AvrA/mAvrA at 35 kDa.
(C–F), Electrospray ionization (ESI) tandem mass spectrometry (MS/MS) spectra of modified tryptic peptide (C) (mass-to-charge ratio [m/z] of 693.37 [z = 3]) and
peptide (D) (m/z of 579.27 [z = 3]) from MKK4-AvrA, peptide (E) (mass-to-charge ratio [m/z] of 565.27 [z = 3]) from rMKK4, and peptide (F) (mass-to-charge ratio
[m/z] of 605.79 [z = 4]) from MKK4-mAvrA. The b and y ions are marked on the MS/MS spectra. The amino acid sequence for each peptide is shown. Putatively
acetylated residues are designated by Ac in the sequence. The abbreviation ppa (proprionamide) is for alkylation of the cysteine residues by acrylamide from
the gel.
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tive site residue modification (Figure 4E and Figure 4F). Thus,
AvrA can act as an acetyltransferase in the manner described
for other members of this family (Mittal et al., 2006; Mukherjee
et al., 2006). Also note that the constitutively active form of Dro-
sophila Hemipterous (MKK4/7) could not be suppressed by AvrA
(Figure 2G), presumably because the T-to-D transition could not
be O-acetylated.
Salmonella AvrA Mediates Suppression of Epithelial
Innate Immunity and Apoptosis during Natural Infection
To evaluate the effect of AvrA in natural infection inmammals, we
turned to a recently developed model of intestinal Salmonellosis
using streptomycin-pretreated mice. This model has been
widely validated and has been used by ourselves and others
as a system that faithfully replicates the acute inflammatory
events on enteric Salmonellosis (Barthel et al., 2003; Vijay-
Kumar et al., 2006). We used wild-type Salmonella SL3201, an
AvrA isogenic Salmonellamutant bearing a nonpolar insertional
mutation in the chromosomal avrA gene, and the AvrA mutant
complemented with wild-type avrA+ (AvrA/pAvrA). Murine
infection with the AvrA Salmonella resulted in elevated levels
of serum KC (the murine ortholog of the neutrophil specific che-
moattractant IL-8) (Figure 5A), relative to infection with isogenic
wild-type Salmonella or the avrA+ complemented mutant, again
consistent with AvrA mediating a repression of innate immune
signaling. Additionally, increased neutrophil influx into the intes-
tinal mucosa was seen inmice infected with AvrASalmonella as
measured by myeloperioxidase (MPO) (Figure 5B), a histochem-
ical marker of neutrophils.
We next sought to determine effects of AvrA on epithelial
apoptosis in the context of natural infection. Infection with
wild-type Salmonella or the avrA+-complemented AvrAmutant
resulted in scattered apical caspase-3 and TUNEL-positive cells,
consistent with our previous observations (Vijay-Kumar et al.,
2006) (Figures 5C and 5D). Strikingly, the isogenic AvrAmutant
elicited a marked increase in both caspase-3 and TUNEL-posi-
tive cells at this time point. From this data, we conclude that
Salmonella AvrA serves to suppress both epithelial innate immu-
nity and apoptosis during the initial phase of Salmonella interac-
tion with the intestinal mucosa.
Finally, we evaluated the effects of AvrA on JNK pathway
activation during initial events of infection using a murine muco-
sal ex vivo model. Intestinal segments were infected for 5 min
with either wild-type Salmonella, AvrA mutant Salmonella, or
the AvrAmutant complemented with wild-type avrA+. Infection
with the AvrA Salmonella resulted in elevated phospho-JNK
levels in cells at the apical regions of the intestinal villi, whereas
infection with the other bacteria did not (Figure 6A). Additionally,
immunoblot analysis of scrapings from intestinal mucosa
showed increased levels of phospho-JNK following infection
by AvrA mutant bacteria, compared to the wild-type or the
Figure 5. Salmonella AvrA Mediates Suppression of Epithelial Innate Immunity and Apoptosis during Natural Infection
Streptomycin-pretreated mice were inoculated with 108 CFUWT Salmonella SL3201 or isogenic AvrAmutant, or a AvrAmutant complemented with wild-type
avrA+ (AvrA/pAvrA) for six hours. (A) KC ELISA from peripheral serum and (B) Myeloperoxidase (MPO) assay for colonic mucosal lysates. (C) Immunohistochem-
ical staining for active caspase-3 and TUNEL stain in colonic mucosa 6 hr post-oral infection with the indicated strain. Five mice were analyzed in each exper-
imental group. (D) Quantification of active-caspase-3 positive cells from (C). *p < 0.05; **p < 0.005; ***p < 0.001.240 Cell Host & Microbe 3, 233–244, April 2008 ª2008 Elsevier Inc.
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these data indicate AvrA suppresses phospho-JNK activation
during the initial phase ofSalmonella contactwith intact epithelia.
DISCUSSION
Drosophila has been a workhorse of modern biology for nearly
a century. The ease of working with this species and the ‘‘genetic
tractability’’ developed over years has led to the use of Drosoph-
ila in many areas of experimental biology, including develop-
ment, cell biology, neuro-, and behavioral biology. However,
only recently has this organism been recognized to possess an
antimicrobial defense system with striking functional and struc-
tural homology to mammalian innate immune networks, thus
allowing this model system to be applied to problems in innate
immunology (Lemaitre and Hoffmann, 2007). Recently, genetic
approaches to the study individual prokaryotic or viral effector
molecules have been attempted (Guichard et al., 2006; Jia
et al., 2006; Leulier et al., 2003) and have shown utility in elucidat-
ing effects of noneukaryotic proteins on an intact animal.
In this report, we examined AvrA in a transgenic Drosophila
genetic model. Our experiments revealed that AvrA mediated
the selective inhibition of the IMD pathway in Drosophila. Dro-
sophila expressing AvrA were highly susceptible to Gram-nega-
tive infection, did not upregulate the Gram-negative-specific
peptide Diptericin, and failed to activate the Gram-negative-spe-
cific Relish factor (assayed by cytoplasmic to nuclear transloca-
tion) upon bacterial challenge. The selective inhibition of the IMD
Figure 6. Salmonella AvrA Mediates Suppression of Phospho-JNK
Activation in the Murine Intestine
Murine intestine was dissected and infected with 109 CFU of WT Salmonella
SL3201, isogenic AvrA mutant, or an AvrA mutant complemented with
wild-type avrA+ (AvrA/pAvrA) for 5 min.
(A) Immunohistochemical staining for p-JNK in intestinal mucosa 5 min
postinfection with the indicated strain.
(B) Immunoblot analysis of mouse intestinal epithelial cells infected for 5 min
with the indicated Salmonella strain with a p-JNK antibody. Relative intensities
of p-JNK band at 46 kDa were measured using Scion Image beta analysis
program (Scion Corporation).pathway, with its specificity toward Gram-negative bacteria, is
consistent with the hypothesized function of a Salmonella effec-
tor protein, itself a Gram-negative pathogen. The IMD pathway,
unlike the Toll pathway, requires activation of MAPKK signaling
intermediates, including Ird5 (Drosophila IKK-b) (Silverman
et al., 2000) and Kenny (Drosophila IKK-g) (Rutschmann et al.,
2000). IMD pathway inhibition by AvrA is highly consistent with
the proposed activities of the AvrA/YopJ effectors as inhibitors
of the MAPKK class of enzymes. Additionally, our data support
previous reports where infection of Drosophila mbn-2-cultured
cells with Salmonella typhimurium dampened AMP activation
via inhibition of the Imd/Relish pathway (Lindmark et al., 2001).
The effects of the Salmonella typhimurium protein AvrA on
cellular innate immune signaling has been studied using mam-
malian cell-based assays (Collier-Hyams et al., 2002). These
experiments showed that overexpressed AvrA suppressed the
canonical NF-kB pathway by inhibiting nuclear translocation of
the p50/p65 Rel proteins, resulting in blockade of NF-kB-depen-
dent promoter activation. These observations are concordant
with the AvrA-mediated inhibition of Relish translocation and
suppression of Rel-dependent diptercin activation in the fat
body of Drosophila, illustrating the conservation of AvrA-medi-
ated effects on this pathway. In both our past manuscripts
(Collier-Hyams et al., 2002) and the current work, we did not
see inhibition of IkB-a phosphorylation but did observe stabiliza-
tion of IkB-a. This is similar to data obtained with overexpressed
YopJ, which while mediating marked inhibition of IKK-b kinase
activation and subsequent stabilization of the IkB-a protein,
showed onlyminimal effects on endogenous IkB-a phosphoryla-
tion (Mittal et al., 2006), possibly suggesting that IKKs have func-
tional targets in the NF-kB pathway distinct from the classic dual
serine motif of IkB-a.
There are three orthologs of AvrA with described activities
toward the MAPKK family and IKKs, and all serve to repress
innate immune responses. YopJ of Yersinia has a wide range
of inhibitory activities against ERK, p38, JNK, and IKK (Orth
et al., 1999), VopA of Vibrio parahemalyticus, which has been
shown to inhibit ERK, p38 and JNK, but not IKK (Trosky et al.,
2007; Trosky et al., 2004), and AopP of Aeromonas salmonicida,
which is apparently specific to IKK (Fehr et al., 2006). Our data is
highly supportive of the concept that these proteins can differen-
tially and variably inhibit members of the MAPKKs and IKKs. In
biochemical and functional analysis directly comparing the abil-
ity of YopJ and AvrA to repress the spectrum of MAPK pathways
in mammalian cells, we showed that AvrA was especially inhibi-
tory to JNK, with lesser activity toward IKK, while YopJ re-
pressed all three MAPK pathways and IKKs. These observations
indicate that bacteria can impinge on innate immune pathways
by targeting multiple different MAPKKs, highlighting the interre-
lated role these pathways have on immune signaling.
Our most unexpected and striking finding was the ability of
AvrA, unique among this class of effectors, to suppress apopto-
sis. AvrA did not result in apoptosis in Drosophila fat body
constitutively or during systemic infection (data not shown).
AvrA did not induce apoptosis during constitutive or induced
expression in Drosophila eye or wing discs, in striking contrast
to the expression of AopP, which was directly and potently proa-
poptotic in these tissues and in transfection experiments in
mammalian cell culture. We show YopJ to be potently
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TNF-a, again in contrast to AvrA, which had no proapoptotic ac-
tivity even in the presence of this cytokine. We previously had re-
ported that infection of cultured HeLa cells with AvrA mutants in
the background of Salmonella strains/species that are nonproin-
flammatory in human cells (Salmonella typhimurium PhoPc, and
S. pullorum) resulted in an increase in the apoptotic cell popula-
tion (Collier-Hyams et al., 2002). However, Ye et al. described re-
duced apoptosis in murine intestine infected with these strains
(Ye et al., 2007). While these in vivo experiments did not use
a proinflammatory pathogenic wild-type host strain, the data
are consistent with AvrA mediating an antiapoptotic role and
suggests results obtained in cell culture represent a situation
idiosyncratic to in vitro systems. In the context of proinflamma-
tory enteropathogenic Salmonellosis, our results suggest AvrA
represses apoptosis during the epithelial step of the infectious
process.
Asmentioned, members of the YopJ-like family of proteins are
well described as having differential inhibitory effects on sub-
strates at the MAPKK level (Mittal et al., 2006; Mukherjee et al.,
2006; Trosky et al., 2007). This selectivity of substrate specificity
likely accounted for the striking differential effects on apoptosis.
In general, JNK is thought of as a proapoptotic pathway, while
ERK and p38 (and NF-kB) are understood as mediating survival
signals (Weston and Davis, 2007). Our data is supportive of this
concept, with AvrA as a JNK inhibitor acting as a survival effector
protein. Furthermore, we show AvrA is able to repress apoptotic
signaling from constitutively active Eiger and the JNK-KK TAK1,
consistent with the known proapoptotic role of sustained JNK
activation (Kamata et al., 2005).
Recent biochemical studies showed YopJ and VopA act as an
acetyltransferase, using acetyl-coenzyme A (CoA) to modify
critical serine and threonine residues of target MAPKKs, thereby
blocking phosphorylation and activation of the protein (Mittal
et al., 2006; Mukherjee et al., 2006; Trosky et al., 2007). The
reported biochemical target of VopA coincides with functional
repression exhibited in our genetic data showing VopA-medi-
ated ERK pathway inhibition at the level of dSor (Drosophila
MKK6). Our molecular data strongly suggested that AvrA inhibits
JNK signaling at the level of the JNK-K (MKK4/7 in mammals,
Hemipterous in Drosophila). Consistently, we used mass spec-
troscopy to evaluate recombinant MKK4 when coexpressed
with AvrA, demonstrating the novel O-acetylation on the Thr res-
idue of the MKK4 activation loop as expected for this class of
bacterial proteins. That a modification of the activation loop is
responsible for the apoptotic repressive action of AvrA is also
strongly supported by genetic data showing a constitutively
active JNK-K (Hemipterous), which is defined by a phospho-
mimeticmutation of the Thr in the activation loop, causes a rough
eye that can not be suppressed by AvrA, while JNK-KK (TAK)-
mediated rough eye is suppressed (Figure 2G). Other reports
have concluded that the YopJ/AvrA proteins function as deubi-
quitinating enzymes (Sweet et al., 2007; Ye et al., 2007; Zhou
et al., 2005). Such a biochemical activity may occur in parallel
with acetyltranferase-mediated inhibition and is not inconsistent
with our observed effects on signaling pathways.
The overall paradigm of defensive response or altruistic cell
loss, as well as the associated biochemical signaling pathways,
is highly conserved across metazoans, including mammals and
242 Cell Host & Microbe 3, 233–244, April 2008 ª2008 Elsevier Inc.invertebrates (Hoffmann, 2003; Silverman and Maniatis, 2001;
Weinrauch and Zychlinsky, 1999). Collectively, our data show
complete concordance of the ability of AvrA to influence specific
MAPKK-mediated signaling, immune activation, and apoptosis
in widely disparate eukaryotic in vivo systems. Salmonella
induces a brisk, but nondestructive, acute inflammatory re-
sponse in the epithelia, both in natural human and model murine
infections. However, murine infection with the AvrA null mutant
resulted in increased cellular inflammation and a massive in-
crease in epithelial apoptosis. Thus, AvrA activity may account
for the self-limited inflammation seen in Salmonellosis, in con-
trast to the more destructive epithelial effects characteristic of
infection by other enteric pathogens such as Shigella and
EHEC (Sansonetti and Di Santo, 2007). The AvrA protein appar-
ently allows the invading bacterium to dampen innate immune
signaling but also prevents the apoptotic elimination in cells
that have perceived microbial compromise.
Conversely, the greater proapoptotic activity of the AvrA
ortholog in Yersinia, YopJ (Mukherjee et al., 2006) (ascribed to
its more promiscuous range of MAPKK inhibitory activity) is con-
sistent with that organism’s ability to rapidly kill phagocytic cells
and mediate a more virulent infection. It appears Salmonella has
refined a similar biochemical activity to mediate a more benign
cellular consequence. Indeed, the existence of related biochem-
ical effectors in plant symbionts (Staskawicz et al., 2001) illus-
trates the exquisite fine tuning of host responses that bacteria
can engender.
EXPERIMENTAL PROCEDURES
Experimental Infection
Infections were performed by stabbing adult Drosophila or third-instar larvae
with a thin tungsten needle dipped in a concentrated pellet of Erwinia caroto-
vora, Eschericia coli, or Micrococcus luteus. Fungal spore infections were
done using the natural fly pathogen Bauvaria bassiana. Cultures of B. bassiana
were propagated in fly vials, whereupon anesthetized flies were passaged into
the vial and covered in fungal spores by shaking the vial for 2 min. Survival
rates were determined by counting survivors at time intervals. Larval infection
was undertaken by parenteral infection with microbially infected needle.
Infected larvae were immediately placed in a Petri dish containing water-
saturated tissue paper to avoid desiccation.
TUNEL Assay
Apoptotic cells were detected by TUNEL assay using an In Situ Cell Death
Detection Kit, Fluorescein (Roche Diagnostics GmbH) according to manufac-
turer’s instructions. Cultured HeLa cells were grown on 10 mm diameter cover
slips in Petri dishes. Following plasmid transfection and treatment with TNFa,
cover slips were removed from Petri dishes, inverted, and sequentially placed
on 100 ml TUNEL assay reagents. Cover slips were then mounted on slides,
and cells viewed by Confocal microscopy. For analysis of TUNEL positive cells
in the intestine of infected mice, paraffin embedded caecal tissue sections
were mounted on slides, and sequentially treated with TUNEL assay reagents.
Tissue sections were then over layed with cover slips and viewed by Confocal
microscopy.
Murine Infections
The creation of an avrA null of Salmonella SL3201 mutant is previously
described (Collier-Hyams et al., 2002). Pathogen-free female BALB/cj mice
(6–8 weeks) were procured from Jackson Laboratories (Bar Harbor, ME).
Animals were deprived of food and water for 4 hr before treatment with
7.5 mg of streptomycin by oral gavage. Afterward, animals were supplied
with food and water ad libitum. At 20 hr poststreptomycin treatment, water
and food were withdrawn again for 4 hr before the mice were infected with
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Salmonella AvrA Suppresses JNK-Mediated Apoptosis108 CFU wild-type Salmonella SL3201, the isogenic avrA mutant form of
SL3201, or the mutant complemented with plasmid expressed AvrA. Con-
struction of these mutants is as described in Collier-Hyams et al. (2002). At
6 hr postinfection, blood samples were collected, and serum KC levels were
determined using a mouse CXC chemokine KC DuoSet kit according to man-
ufacturer’s instructions (R&D Systems, Minneapolis, MN). Thereafter, ceca
were removed, and neutrophil infiltration into tissue was quantified bymeasur-
ing MPO enzyme activity (a marker for neutrophils) by biochemical assay. His-
tological sections of ceca were prepared from five infected animals per treat-
ment. Sections were assessed for active caspase-3 activity by numeration by
the average number of positive cells in forty 2003 fields per infected animal.
Animal experiments were approved by the Emory University institutional
ethical committee and performed according to the legal requirements.
For ex vivo analysis of phospho-JNK activation in murine gut, small intes-
tines were removed from 8-week-old BALB/cj mice, and 2 cm segments
were immediately placed in Hank’s buffer at 37C. The segments were then
infected with Salmonella cultures (109 CFU/ml) for time periods up to 1 hr.
Infected and control segments were opened along the mesenteric border,
and epithelial tissue was scraped and lysed by homogenization in RIPA buffer
(100 mg tissue per milliliter of buffer) and centrifuged at 16,000 rpm. for 20 min
at 4C. Protein concentrations of supernatants were determined by protein
assay (Bio-Rad), and equal amounts of protein were diluted with denaturing
SDS-PAGE loading buffer and assayed by immunoblot.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
four supplemental figures and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/3/4/233/DC1/.
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